DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
28 hedge funds and large institutions have $758K invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 7 closing their positions.
Holders
28
Holders Change
-6
Holders Change %
-17.65%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
1
Increased
2
Reduced
3
Closed
7
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
-$6K
Top Buyers
| 1 |
CAC
1
Cowen and Company
New York
|
$124K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$1.84K |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$64.7K |
| 2 |
ICM
2
Ionic Capital Management
New York
|
$0 |
| 3 |
SC
3
Shay Capital
New York
|
$0 |
| 4 |
LC
4
Lindbrook Capital
Calabasas,
California
|
$0 |
| 5 |
5
Jane Street
New York
|
$0 |
